These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24512726)

  • 1. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells.
    Shuliang S; Lei C; Guangwu J; Changjie L
    Oncol Res; 2013; 21(3):121-7. PubMed ID: 24512726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
    Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
    Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
    Wen M; Kwon Y; Wang Y; Mao JH; Wei G
    Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ubiquitin-conjugating enzyme 2C on invasion, proliferation and cell cycling of lung cancer cells.
    Tang XK; Wang KJ; Tang YK; Chen L
    Asian Pac J Cancer Prev; 2014; 15(7):3005-9. PubMed ID: 24815438
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Liu Y; Zhao R; Chi S; Zhang W; Xiao C; Zhou X; Zhao Y; Wang H
    Mol Cancer Res; 2020 Feb; 18(2):204-215. PubMed ID: 31662448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.
    Xie C; Powell C; Yao M; Wu J; Dong Q
    Int J Biochem Cell Biol; 2014 Feb; 47():113-7. PubMed ID: 24361302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.
    Zhang Z; Liu P; Wang J; Gong T; Zhang F; Ma J; Han N
    Med Oncol; 2015 May; 32(5):149. PubMed ID: 25832867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer.
    Wu X; Long X; Ma C; Cheuk YC; Hu M; Hu J; Jiang H
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells.
    Xiong Y; Lu J; Fang Q; Lu Y; Xie C; Wu H; Yin Z
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30914455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.
    Ieta K; Ojima E; Tanaka F; Nakamura Y; Haraguchi N; Mimori K; Inoue H; Kuwano H; Mori M
    Int J Cancer; 2007 Jul; 121(1):33-8. PubMed ID: 17354233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.
    Wang H; Zhang C; Rorick A; Wu D; Chiu M; Thomas-Ahner J; Chen Z; Chen H; Clinton SK; Chan KK; Wang Q
    Cancer Res; 2011 Jul; 71(14):4866-76. PubMed ID: 21593191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits prostate cancer by upregulating miR-483-3p and inhibiting UBE2C.
    Li W; Wang F; Wang X; Xu W; Liu F; Hu R; Li S
    J Biochem Mol Toxicol; 2024 Feb; 38(2):e23645. PubMed ID: 38348716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.
    Han Q; Zhou C; Liu F; Xu G; Zheng R; Zhang X
    Oncol Rep; 2015 Aug; 34(2):877-83. PubMed ID: 26062455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation.
    Bose MV; Gopisetty G; Selvaluxmy G; Rajkumar T
    Int J Radiat Biol; 2012 Sep; 88(9):629-34. PubMed ID: 22694363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
    Wang R; Song Y; Liu X; Wang Q; Wang Y; Li L; Kang C; Zhang Q
    Int J Oncol; 2017 Apr; 50(4):1116-1126. PubMed ID: 28260026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells.
    Zhang S; You X; Zheng Y; Shen Y; Xiong X; Sun Y
    J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36548081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of UBE2C in Brain Cancer Invasion and Dissemination.
    Domentean S; Paisana E; Cascão R; Faria CC
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition.
    Zhang Y; Li X; Gong Y; Du D; Chen H; Liu L; Cheng Z
    Medicine (Baltimore); 2023 May; 102(20):e33834. PubMed ID: 37335710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.